Faecal microbiome of NSCLC patients in Poland
The main objective of this study was compare of the gut microbiome from 47 NSCLC patients treated in the first or second line with anti-PD-1(anti-programmed death-ligand 1) or anti-PD-L1 (anti-programmed death receptor 1) monoclonal antibodies.